Lanot, Nicolas http://orcid.org/0000-0003-2712-0304
Vincenti, Marie http://orcid.org/0000-0002-8201-5024
Abassi, Hamouda http://orcid.org/0000-0002-1876-5701
Bredy, Charlene
Agullo, Audrey http://orcid.org/0000-0001-5979-7921
Gamon, Lucie http://orcid.org/0000-0003-0322-3384
Mura, Thibault http://orcid.org/0000-0001-6420-1336
Lavastre, Kathleen
De La Villeon, Gregoire http://orcid.org/0000-0002-3495-0173
Barrea, Catherine http://orcid.org/0000-0001-5008-0764
Meyer, Pierre http://orcid.org/0000-0001-5710-7376
Rivier, François http://orcid.org/0000-0002-3896-8792
Meli, Albano C. http://orcid.org/0000-0002-1727-3027
Fauconnier, Jeremy
Cazorla, Olivier http://orcid.org/0000-0003-0775-203X
Lacampagne, Alain http://orcid.org/0000-0003-0264-1787
Amedro, Pascal http://orcid.org/0000-0003-3649-0294
Funding for this research was provided by:
Centre Hospitalier Régional Universitaire de Montpellier (PHRC-MERRI UF 9458)
French Muscular Dystrophy Association (AFM 20225)
Article History
Received: 9 May 2021
Accepted: 27 July 2021
First Online: 14 December 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: Informed consent was obtained from all parents or legal guardians.
: Informed consent was obtained from all parents or legal guardians. Only anonymized data has been published.
: The study was conducted in compliance with the Good Clinical Practices protocol and Declaration of Helsinki principles. The South Mediterranean IV Ethics Committee (2014-A01764-44) in France and the UCL Ethics Committee (2016-28AVR-192) in Belgium approved the study, which was registered on ClinicalTrials.gov (NCT02418338)
: Informed consent was obtained from all parents or legal guardians.